共 50 条
Strategies to engineer tendon/ligament-to-bone interface: Biomaterials, cells and growth factors
被引:199
|作者:
Tellado, Sonia Font
[1
]
Balmayor, Elizabeth R.
[1
]
Van Griensven, Martijn
[1
]
机构:
[1] Tech Univ Munich, Dept Expt Trauma Surg, Klinikum Rechts Isar, D-81675 Munich, Germany
关键词:
Tissue engineering;
Interface;
Enthesis;
Bone;
Tendon;
Ligament;
MESENCHYMAL STEM-CELLS;
ANTERIOR CRUCIATE LIGAMENT;
CONTROLLED-RELEASE STRATEGIES;
CYCLIC TENSILE STRAIN;
IN-VITRO EVALUATION;
CHONDROGENIC DIFFERENTIATION;
TENOGENIC DIFFERENTIATION;
MORPHOGENETIC PROTEIN-2;
NANOFIBER SCAFFOLDS;
CONTROLLED DELIVERY;
D O I:
10.1016/j.addr.2015.03.004
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Integration between tendon/ligament and bone occurs through a specialized tissue interface called enthesis. The complex and heterogeneous structure of the enthesis is essential to ensure smooth mechanical stress transfer between bone and soft tissues. Following injury, the interface is not regenerated, resulting in high rupture recurrence rates. Tissue engineering is a promising strategy for the regeneration of a functional enthesis. However, the complex structural and cellular composition of the native interface makes enthesis tissue engineering particularly challenging. Thus, it is likely that a combination of biomaterials and cells stimulated with appropriate biochemical and mechanical cues will be needed. The objective of this review is to describe the current state-of-the-art, challenges and future directions in the field of enthesis tissue engineering focusing on four key parameters: (1) scaffold and biomaterials, (2) cells, (3) growth factors and (4) mechanical stimuli. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:126 / 140
页数:15
相关论文